ES8300785A1 - Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios - Google Patents

Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios

Info

Publication number
ES8300785A1
ES8300785A1 ES504340A ES504340A ES8300785A1 ES 8300785 A1 ES8300785 A1 ES 8300785A1 ES 504340 A ES504340 A ES 504340A ES 504340 A ES504340 A ES 504340A ES 8300785 A1 ES8300785 A1 ES 8300785A1
Authority
ES
Spain
Prior art keywords
beta
alpha
carbothioates
androstene
carboxylates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES504340A
Other languages
English (en)
Spanish (es)
Other versions
ES504340A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8300785A1 publication Critical patent/ES8300785A1/es
Publication of ES504340A0 publication Critical patent/ES504340A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES504340A 1980-07-10 1981-07-10 Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios Granted ES504340A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16845380A 1980-07-10 1980-07-10
US26578581A 1981-05-21 1981-05-21

Publications (2)

Publication Number Publication Date
ES8300785A1 true ES8300785A1 (es) 1982-12-01
ES504340A0 ES504340A0 (es) 1982-12-01

Family

ID=26864131

Family Applications (2)

Application Number Title Priority Date Filing Date
ES504340A Granted ES504340A0 (es) 1980-07-10 1981-07-10 Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
ES514633A Expired ES8306767A1 (es) 1980-07-10 1982-08-02 "metodo de preparar compuestos esteroidicos antiinflamatorios".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES514633A Expired ES8306767A1 (es) 1980-07-10 1982-08-02 "metodo de preparar compuestos esteroidicos antiinflamatorios".

Country Status (17)

Country Link
KR (2) KR860000266B1 (de)
AT (1) AT379816B (de)
AU (1) AU540898B2 (de)
CA (1) CA1174667A (de)
CH (1) CH648856A5 (de)
DE (1) DE3126732C2 (de)
DK (1) DK165837C (de)
ES (2) ES504340A0 (de)
FI (1) FI71748C (de)
FR (1) FR2486529A1 (de)
GB (1) GB2079755B (de)
IT (1) IT1205446B (de)
NL (1) NL192343C (de)
NO (1) NO163285C (de)
PH (1) PH25874A (de)
PT (1) PT73348B (de)
SE (1) SE449106B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
JPS6041607A (ja) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd 軟膏基剤
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
DE3786174T2 (de) * 1987-10-13 1993-10-21 Nicholas S Bodor Weiche steroide mit anti-entzündungswirkung.
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
JP2000513380A (ja) * 1997-06-30 2000-10-10 グラクソ、グループ、リミテッド 化合物
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
PT2348032E (pt) 2000-08-05 2015-10-14 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-'(2-furanilcarboxil)oxi]-11.beta.-hidroxi-16.alfa.- metil-3-oxo-androsta-1,4-dieno-17-carbotióico como um agente anti-inflamatório
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
WO2006072599A2 (en) 2005-01-10 2006-07-13 Glaxo Group Limited Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
CN101942001B (zh) * 2010-08-24 2013-02-06 山东省医药工业研究所 一种氯替泼诺的提纯方法
CN103183714A (zh) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 一种氯替泼诺的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
IT1114534B (it) * 1978-02-08 1986-01-27 Glaxo Group Ltd Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK302181A (da) 1982-01-11
NL192343B (nl) 1997-02-03
SE449106B (sv) 1987-04-06
FR2486529A1 (fr) 1982-01-15
GB2079755A (en) 1982-01-27
GB2079755B (en) 1985-01-30
DE3126732C2 (de) 1987-04-30
IT8105186A0 (it) 1981-07-09
KR860000266B1 (ko) 1986-03-22
AU540898B2 (en) 1984-12-06
NL192343C (nl) 1997-06-04
SE8104132L (sv) 1982-01-11
ES504340A0 (es) 1982-12-01
ES514633A0 (es) 1983-06-16
CH648856A5 (de) 1985-04-15
PT73348B (en) 1982-09-23
FI71748C (fi) 1987-02-09
KR830006327A (ko) 1983-09-24
FI71748B (fi) 1986-10-31
IT1205446B (it) 1989-03-23
NO163285C (no) 1990-05-02
AT379816B (de) 1986-03-10
NO812344L (no) 1982-01-11
ATA307081A (de) 1985-07-15
KR850002759A (ko) 1985-05-15
DE3126732A1 (de) 1982-03-25
FI812175L (fi) 1982-01-11
NO163285B (no) 1990-01-22
FR2486529B1 (de) 1985-01-04
CA1174667A (en) 1984-09-18
DK165837B (da) 1993-01-25
ES8306767A1 (es) 1983-06-16
KR860000452B1 (ko) 1986-04-26
PH25874A (en) 1991-12-02
NL8103315A (nl) 1982-02-01
PT73348A (en) 1981-08-01
AU7259181A (en) 1982-01-14
DK165837C (da) 1993-06-21

Similar Documents

Publication Publication Date Title
ES8300785A1 (es) Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
ES8701733A1 (es) Procedimiento para detectar peroxido de hidrogeno o sustancias formadoras de peroxido de hidrogeno
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
ES8104321A1 (es) Procedimiento para separar un derivado de alquil-cetohexopi-ranosida
ES8101530A1 (es) Un procedimiento para la preparacion de alcoholes beta-gama-dihidro-poliprenilicos.
ES445775A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-hidroxi-4-fluor-butirofenona.
ES8607935A1 (es) Un procedimiento de preparar un derivado de ariltio-piridi- nil-alcanol
GB1292737A (en) Haloepoxides
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
CA1273946C (en) ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES
ES459197A1 (es) Procedimiento para preparar esteres oximicos de isonitroso- cianoacetamida.
JPS5416485A (en) Pyridazinone derivatives and their preparation
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos
ES8502700A1 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES455834A1 (es) Procedimientos para la preparacion de derivados de la pipe- ridina.
SE8303569D0 (sv) Polyprenylforeningar
ES8705426A1 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES471492A1 (es) Procedimiento para la preparacion de nuevas isoquinoleindio-nas que contienen azufre
ES8405033A1 (es) Procedimiento para la obtencion de esteroides dihalogenados.
ES8403102A1 (es) Un procedimiento para la preparacion de esteres fluorofenoxibencilicos.
ES443309A1 (es) Procedimiento para la obtencion de amidas de esteres de aci-dos s-(fenoximetil)-ditiofosforicos.
ES8201205A1 (es) Procedimiento para la preparacion de nuevos compuestos de aminoantipirina
ES479478A1 (es) Procedimiento para preparar derivados del isocromano.
SU701101A1 (ru) Производные 2-х-бензилиденгидразино-4-фенил-5n-r- сульфамоилфенилазотиазола, обладающие акарицидной активностью
JPS5344573A (en) Optical active 2-piperidineethanols and their preparation